Hepatitis C patients with HIV may face higher risk of liver dise - KFDA - NewsChannel 10 / Amarillo News, Weather, Sports

Hepatitis C patients with HIV may face higher risk of liver disease

Updated: March 19, 2014 09:13 AM
© iStockphoto.com © iStockphoto.com

WEDNESDAY, March 19, 2014 (HealthDay News) -- Among people with hepatitis C, the risk of serious liver disease is much higher in those who also have HIV than in those without the AIDS-causing virus, a new study finds.

This is true even among patients with HIV who are otherwise benefiting from antiretroviral therapy to treat the virus, the University of Pennsylvania researchers said.

They analyzed data from more than 4,200 patients with both hepatitis C and HIV who were receiving antiretroviral therapy. In addition, they looked at data on more than 6,000 patients with hepatitis C only. The patients received care between 1997 and 2010.

The HIV/hepatitis C patients had an 80 percent higher rate of serious liver disease than those with hepatitis C only, according to the study, which was published in the March 18 issue of the journal Annals of Internal Medicine.

Even HIV/hepatitis C patients who had a good response to antiretroviral therapy for HIV still had a 60 percent higher rate of serious liver disease than those with hepatitis C alone.

Serious liver diseases were higher among HIV/hepatitis C patients with advanced liver fibrosis, diabetes and severe anemia, and among those who weren't black, the study also found.

"Our results suggest that serious consideration should be given to initiating hepatitis C treatment in patients co-infected with HIV and hepatitis C -- particularly among those with advanced liver fibrosis or cirrhosis -- in order to try to reduce the risk of serious, potentially life-threatening liver complications," study lead author Dr. Vincent Lo Re III, said in a university news release.

Lo Re is an assistant professor of medicine and epidemiology in the university's division of infectious diseases and the department of biostatistics and epidemiology, as well as an investigator at the Penn Center for AIDS Research.

"By taking action sooner, we may be able to reduce the risk of advanced liver disease in co-infected patients," Lo Re added.

About 20 percent to 30 percent of HIV patients also have hepatitis C, likely due to shared causes of infection.

More information

AIDS.gov has more about HIV and hepatitis.

Copyright © 2014 HealthDay. All rights reserved.

  • Health WatchMore>>

  • House approves VA health care overhaul

    House approves VA health care overhaul

    Wednesday, July 30 2014 9:12 PM EDT2014-07-31 01:12:40 GMT
    With a new Veterans Affairs secretary in place and an August recess looming, Congress is moving quickly to approve a compromise bill to refurbish the VA and improve veterans' health care.
    The House overwhelmingly approved a landmark bill Wednesday to help veterans avoid long waits for health care that have plagued the Veterans Affairs Department for years.
  • $1,000 Sovaldi now hepatitis treatment of choice

    $1,000 Sovaldi now hepatitis treatment of choice

    Wednesday, July 30 2014 8:58 PM EDT2014-07-31 00:58:45 GMT
    A $1,000-per-pill drug that insurers are reluctant to pay for has quickly become the treatment of choice for a liver-wasting viral disease that affects more than 3 million Americans.
    The price is sky-high, but so is demand. A new $1,000-per-pill drug has become the treatment of choice for Americans with hepatitis C, a liver-wasting disease that affects more than 3 million.
  • Deportations halted at New Mexico processing center

    Deportations halted at New Mexico processing center

    Deportations halted at New Mexico processing center

    Artesia, NM - Officials at an immigration processing center in new mexico announced they will be halting all deportations for the time being.
    Artesia, NM - Officials at an immigration processing center in new mexico announced they will be halting all deportations for the time being.
*DISCLAIMER*: The information contained in or provided through this site section is intended for general consumer understanding and education only and is not intended to be and is not a substitute for professional advice. Use of this site section and any information contained on or provided through this site section is at your own risk and any information contained on or provided through this site section is provided on an "as is" basis without any representations or warranties.